Pharm (Day 6) Flashcards

1
Q

Benzo Pharmacokinetics

A
  1. Pharmacokinetics
    a. Absorbed by GI tract and metabolized by liver = dose adjustment if liver disease or older age & interaction with inhibitors of cyp 3A4
    b. Accumulation of metabolites = Decreased LOC
  2. Pharmacodynamics
  3. bind to GABA-A receptor
  4. Binding tiggers influx of Cl – ions leading to hyperpolarization of membrane
  5. Reduced firing of neurons = decreased spinal cord activity, cerebral cortex, CSTS Circuit, amygdala circuit.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Propofol indication, dose, conc, metabolism

A

Indication = induction and maintenance of general anesthesia, sedation
Given IV, Must open vent cap to use it during infusion
Dose: 1-2mg/kg in stable patient, 0.5mg/kg unstable
Maintenance: 25-100 mcg/kg/min
Concentration: 1000mg/ 100mL (1%) ITS BLUE and 2000mg / 100mL its YELLOW and has a RED bar
Metabolism and Excretion = Redistribution, hepatic conjugation/renal clearance
Must increase if the patient uses ETOH heavily as Ethanol downregulation from GABA receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Propofol mechanism

A
  1. Allosterically increases the binding affinity of inhibitory neurotransmitter GABA for GABAa receptor = Injection site pain
  2. Prolonged opening of chloride channel
  3. Hyperpolarization of nerve membrane
  4. Inhibitory effect on CNS =
    CNS = Reduced Cerebral metabolic rate, cerebral oxygen consumption, intracranial pressure
    CVS = Reduced systemic vascular resistance, preload and contractility = hypotension
    Resp = Reduced hypoxic and hypercapnic respiratory drive = Hypoxia, Hypercapnia, Apnea
    Decreased upper airway reflexes
  5. Induction/maintenance of general anesthesia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Succinylcholine mechanisms

A

Succinylcholine mimics Ach in structure:

Agonist at nicotinic Ach receptors in muscle
2. Generates action potential
3. Not affected by synaptic acetylcholinesterase (unlike Ach)
4. Continuous end-plate depolarization = Fasciculation, Myalgia = Serum K increase (esp in patients with muscle trauma, denervation or immobilization = Hyperkalemia = Cardiac Arrest
5. Inactivation of sodium channels
6. Prevention of repolarization and additional action potentials
7. Skeletal muscle paralysis

Agonist at nicotinic receptors in parasympathetic ganglia, sympathetic ganglia, and muscarinic receptors in SA node of Heart
1. Parasympathetic effect = down HR, down Contractility
2. Sympathetic effects (high dose succinylcholine) = increased HR, Increased Contractility, Catecholamine release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Succinylcholine indications dose excretion

A

Neuromuscular blockade for endotracheal intubation, surgery, or mechanical ventilation (as adjunct to
general anesthesia):
IM: Up to 3 to 4 mg/kg, maximum total dose: 150 mg.
IV: Intubation: 0.6 mg/kg (range: 0.3 to 1.1 mg/kg).
Rapid-sequence intubation (off-label dosing): 1 to 1.5 mg/kg

Metabolism & Excretion = redistribution and metabolism by pseudocholinesterase in blood plasma and liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Effect of Substance P in the brain

A

function is as a neurotransmitter and a modulator of pain perception by altering cellular signaling pathways.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

GABA effect in brain

A

Primarily neural inhibitor
Reduce neuronal excitability by inhibiting nerve transmission.
It causes prolonged opening of chloride channels which causes a Hyperpolarization of nerve membrane, which causes inhibition.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

glutamate effect in brain

A

glutamate is the most abundant excitatory neurotransmitter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ketamine ind, route, metabolism

A

Anesthesia
IV/IM
Dose: 0.5-1mg for unstable
Mechanism:
agonist at NMDA receptor
agonist at the opioid receptor
antagonist at the muscarinic receptor
enhance central/peripheral monoaminergic transmission
Metabolism: Hepatic
Elimination: Urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Opioid receptor agonist peripheral actions

A

Direct stimulation of mast cells (Histamine release)
Direct stimulation of CTZ (Nausea/vomiting)
u2-receptor agonism in EN5 (Constipation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Levophed Ind, dose, metabolism

A

BP in acute hypotensive stare or shock
Cerebral perfusion in patients with cerebral vasospasm
Dose: 2-4mcg/min titrate up every 10-15 minutes to desired pressure
Mechanism : Stimulates Alpha and Beta 1 receptors
Metabolism: Norepinephrine is metabolized in the liver and other tissues by a combination of reactions involving the enzymes catechol-O-methyltransferase (COMT) and MAO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Dopamine

A

Increase cardiac output for shock due to MI, Sepsis, trauma, cardiac surgery, spinal cord injury and chronic CHF
Mechanism: Alpha and beta
Dose: 1-5 mcg/kg/min increase rate by 1-4 mcg/kg/min every 10-30 minutes
Usual range 20mcg/kg/min
Max 50mcg/kg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Dobutamine

A

INODILATOR
Inotropic agents may be considered in patients with a low cardiac index and low BP, but without hypotension.
Short-term management of patients with cardiogenic decompensation.
Mechanism: Minor alpha, strong beta
Dose: 2-20mcg/kg/min
Metabolism: In tissues and hepatically to inactive metabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Phenylephrine

A

Vasodilatory shock
Mechanism: Pure alpha
50-200mcg IV Direct
100 to 180mcg/min continous IV infusion when stabilized maintain at 40-60mcg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Vasopressin

A

Organ donor: 0.04U/min
Septic shock: 0.01-0.04U/min
Mechanism: V1 and V2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Milrinone

A

CHF
Mechanism: Phosphodiesterase Inhibitor, Target cAMP, post-receptor
Dose: 50mcg/kg over 10 minutes
then 0.125-0.75 mcg/kg/min titrate at 6-8HR intervals
Cerebral vasospasm 0.125-1.5mcg/kg/min

17
Q

Rocuronium

A

Skeletal paralysis to facilitate tracheal intubation.
Dose for exam 1mg/kg
Mechanism:
Competitive agonist at post synaptic nicotinic receptors on muscles
Decreased binding sites for ACh at post synaptic nicotinic receptors on muscles
Decreased muscle cell depoloarisation
Skeletal muscle paralysis
Metabolism and Excretion: redistribution, hepatic clearance/renal excretion (NOT degraded by acetylcholinesterase or pseudocholinesterase)

18
Q

Inodilator

A

cardiosupportive effects (positive inotropy, chronotropy, etc) combined with arterial vasodilation, thus reducing cardiac afterload

19
Q

InoPressor

A

a combination of vasopressors and inotropes, because they lead to both increased cardiac contractility and increased peripheral vasoconstriction

20
Q

Pure Vasopressor

A

drugs that induce vasoconstriction and thereby elevate mean arterial pressure

21
Q

Milrinone Contra-Indication

A

During acute phase of MI
Patients with severe aortic or pulmonary vascular disease